Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk (original) (raw)

• An HX, Claas A, Savelyeva L, Seitz S, Schlag P, Scherneck S et al. (1999). Two regions of deletion in 9p23–24 in sporadic breast cancer. Cancer Res 59: 3941–3943.
  CAS PubMed Google Scholar
• Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS et al. (2004). A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 75: 460–474.
  Article CAS PubMed PubMed Central Google Scholar
• Bartlett C, Stammler T, Rosson GS, Weissman BE . (2010). BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell cycle arrest. J Cell Physiol (e-pub ahead of print).
• Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS et al. (2000). BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102: 257–265.
  Article CAS PubMed Google Scholar
• Bourachot B, Yaniv M, Muchardt C . (2003). Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation. EMBO J 22: 6505–6515.
  Article CAS PubMed PubMed Central Google Scholar
• Chen PY, Meister G . (2005). MicroRNA-guided posttranscriptional gene regulation. Biol Chem 386: 1205–1218.
  Article CAS PubMed Google Scholar
• DeCristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE . (2001). Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 186: 136–145.
  Article CAS PubMed Google Scholar
• Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J et al. (1994). The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119–130.
  Article CAS PubMed Google Scholar
• Fickett JW . (1996). Quantitative discrimination of MEF2 sites. Mol Cell Biol 16: 437–441.
  Article CAS PubMed PubMed Central Google Scholar
• Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A et al. (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 10: 4314–4324.
  Article CAS PubMed Google Scholar
• Gaillard H, Fitzgerald DJ, Smith CL, Peterson CL, Richmond TJ, Thoma F . (2003). Chromatin remodeling activities act on UV-damaged nucleosomes and modulate DNA damage accessibility to photolyase. J Biol Chem 278: 17655–17663.
  Article CAS PubMed Google Scholar
• Gazdar AF, Boffetta P . (2010). A risky business--identifying susceptibility loci for lung cancer. J Natl Cancer Inst 102: 920–923.
  Article PubMed Google Scholar
• Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD . (2000). Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60: 4894–4906.
  CAS PubMed Google Scholar
• Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D . (2007). The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene 26: 7058–7066.
  Article CAS PubMed Google Scholar
• Gramling S, Rogers C, Liu G, Reisman D . (2011). Pharmacologic reversal of epigenetic silencing of the anticancer protein, BRM, a novel targeted treatment strategy. Oncogene 30: 3289–3294.
  Article CAS PubMed PubMed Central Google Scholar
• Gramling S, Reisman D . (2011). Discovery of BRM targeted therapies: novel reactivation of an anticancer gene. Lett Drug Design Dis 8: 93–99.
  Article CAS Google Scholar
• Gregoire S, Xiao L, Nie J, Zhang X, Xu M, Li J et al. (2007). Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol 27: 1280–1295.
  Article CAS PubMed Google Scholar
• Gunduz E, Gunduz M, Ali MA, Beder L, Tamamura R, Katase N et al. (2009). Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma. Cancer Invest 27: 661–668.
  Article CAS PubMed Google Scholar
• Hill DA, de la Serna IL, Veal TM, Imbalzano AN . (2004). BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2. J Cell Biochem 91: 987–998.
  Article CAS PubMed Google Scholar
• Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D et al. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633–637.
  Article CAS PubMed Google Scholar
• John T, Liu G, Tsao MS . (2009). Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. Oncogene 28 (Suppl 1): S14–S23.
  Article CAS PubMed Google Scholar
• Klochendler-Yeivin A, Muchardt C, Yaniv M . (2002). SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev 12: 73–79.
  Article CAS PubMed Google Scholar
• Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M et al. (2009). A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679–691.
  Article CAS PubMed PubMed Central Google Scholar
• Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH et al. (2008). Environment and genetics in lung cancer etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 8: 203.
  Article PubMed PubMed Central Google Scholar
• Liu G, Zhou W, Christiani DC . (2005). Molecular epidemiology of non-small cell lung cancer. Semin Respir Crit Care Med 26: 265–272.
  Article CAS PubMed Google Scholar
• Morrison AJ, Shen X . (2006). Chromatin modifications in DNA repair. Results Probl Cell Differ 41: 109–125.
  Article CAS PubMed Google Scholar
• Muchardt C, Bourachot B, Reyes JC, Yaniv M . (1998). ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J 17: 223–231.
  Article CAS PubMed PubMed Central Google Scholar
• Muchardt C, Yaniv M . (2001). When the SWI/SNF complex remodels the cell cycle. Oncogene 20: 3067–3075.
  Article CAS PubMed Google Scholar
• Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ . (2009). The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28: 2492–2501.
  Article CAS PubMed PubMed Central Google Scholar
• Oh J, Sohn DH, Ko M, Chung H, Jeon SH, Seong RH . (2008). BAF60a interacts with p53 to recruit the SWI/SNF complex. J Biol Chem 283: 11924–11934.
  Article CAS PubMed Google Scholar
• Otsuki T, Furukawa Y, Ikeda K, Endo H, Yamashita T, Shinohara A et al. (2001). Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum Mol Genet 10: 2651–2660.
  Article CAS PubMed Google Scholar
• Park JH, Park EJ, Hur SK, Kim S, Kwon J . (2009). Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage. DNA Repair (Amst) 8: 29–39.
  Article CAS Google Scholar
• Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN et al. (2006). Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J 25: 3986–3997.
  Article CAS PubMed PubMed Central Google Scholar
• Patrone G, Puppo F, Cusano R, Scaranari M, Ceccherini I, Puliti A et al. (2000). Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. Biotechniques 29: 1012–1014.
  Article CAS PubMed Google Scholar
• Reisman D, Glaros S, Thompson EA . (2009). The SWI/SNF complex and cancer. Oncogene 28: 1653–1668.
  Article CAS PubMed Google Scholar
• Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK . (2005). The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl Immunohistochem Mol Morphol 13: 66–74.
  Article CAS PubMed Google Scholar
• Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE . (2003). Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63: 560–566.
  CAS PubMed Google Scholar
• Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser Jr W, Murchardt C et al. (2002). Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196–1207.
  Article CAS PubMed Google Scholar
• Sabah M, Cummins R, Leader M, Kay E . (2005). Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p. Virchows Arch 446: 251–258.
  Article PubMed Google Scholar
• Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, Tagawa T et al. (2011). MicroRNAs miR-199a-5p and -3p Target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 71: 1680–1689.
  Article CAS PubMed Google Scholar
• Sarkar S, Roy BC, Hatano N, Aoyagi T, Gohji K, Kiyama R . (2002). A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J Biol Chem 277: 36585–36591.
  Article CAS PubMed Google Scholar
• Solomon B, Varella-Garcia M, Camidge DR . (2009). ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol 4: 1450–1454.
  Article PubMed Google Scholar
• Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN et al. (2000). BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97: 7748–7753.
  Article CAS PubMed PubMed Central Google Scholar
• Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE et al. (2002). Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J Biol Chem 277: 4782–4789.
  Article CAS PubMed Google Scholar
• Strober BE, Dunaief JL, Guha, Goff SP . (1996). Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 16: 1576–1583.
  Article CAS PubMed PubMed Central Google Scholar
• Tripathi A, Dasgupta S, Roy A, Sengupta A, Roy B, Roychowdhury S et al. (2003). Sequential deletions in both arms of chromosome 9 are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Exp Clin Cancer Res 22: 289–297.
  CAS PubMed Google Scholar
• Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, Rosenberger A et al. (2010). Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 102: 959–971.
  Article CAS PubMed PubMed Central Google Scholar
• Wang M, Gu C, Qi T, Tang W, Wang L, Wang S et al. (2007). BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription. J Biochem 142: 613–620.
  Article CAS PubMed Google Scholar
• Xu Y, Zhang J, Chen X . (2007). The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem 282: 37429–37435.
  Article CAS PubMed Google Scholar
• Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, Kobayashi N et al. (2005). The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 24: 5471–5481.
  Article CAS PubMed Google Scholar
• Yue J, Tigyi G . (2006). MicroRNA trafficking and human cancer. Cancer Biol Ther 5: 573–578.
  Article CAS PubMed Google Scholar